Premium
Erlotinib might be a double‐edged sword in HCC
Author(s) -
Dong JinZhong,
Wang LiPing,
Zhang SaiNan,
Zou ZhuoLin,
Lu MingQin
Publication year - 2015
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.27205
Subject(s) - erlotinib , medicine , erlotinib hydrochloride , epidermal growth factor receptor , hepatocellular carcinoma , hepatology , lung cancer , cirrhosis , pharmacology , cancer research , oncology , cancer